Corpus Intelligence IC Memo — TRUMBULL MEMORIAL HOSPITAL 2026-04-26 10:39 UTC
IC Memo — TRUMBULL MEMORIAL HOSPITAL
Investment Committee Memorandum | OH | 197 beds | Grade C | EBITDA uplift $10.6M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

TRUMBULL MEMORIAL HOSPITAL

CCN 360055 | TRUMBULL, OH | 197 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

TRUMBULL MEMORIAL HOSPITAL is a 197-bed suburban community hospital in TRUMBULL, OH with $143.9M in net patient revenue and a 1.4% operating margin. The hospital serves a payer mix of 22.8% Medicare, 6.2% Medicaid, and 70.9% commercial.

Thesis: Undervalued. Our ML models identify $10.6M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 1.4% to 8.7% (+736bps).

Net Revenue HCRIS$143.9M
Current EBITDA COMPUTED$2.0M
Operating Margin COMPUTED1.4%
Occupancy HCRIS45.0%
Revenue / Bed COMPUTED$731K
Net-to-Gross HCRIS17.6%
Distress Probability ML49.2%

2. Market Context & Competitive Position

235
OH Hospitals
-0.3%
State Median Margin
78
Comparable Hospitals

OH has 235 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 1.4% places it above the state median. Among 78 size-comparable peers (98-394 beds), the median margin is 0.6%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (98-394), prioritizing same-state peers. 78 hospitals in the comp set.

HospitalStateBedsRevenueMargin
TRUMBULL MEMORIAL HOSPITAL (Target)OH197$143.9M1.4%
RAINBOW BABIES & CHILDRENS HOSOH231$2.22B-5.0%
ARTHUR G JAMES CANCER HOSPITALOH356$1.95B21.0%
GOOD SAMARITAN HOSPITALOH361$870.9M3.5%
KETTERING HEALTH MAIN CAMPUSOH383$722.7M-0.7%
KETTERING HEALTH DAYTONOH317$667.6M3.3%
AULTMAN HOSPITALOH365$586.2M-5.6%
DAYTON CHILDRENS HOSPITALOH181$569.1M7.9%
GENESIS HEALTHCARE SYSTEMOH282$527.6M0.6%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $10.6M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$3.0M+210bp18mo
Cost to Collect4.5%2.5%$2.9M+200bp12mo
Denial Rate Reduction12.0%6.5%$2.8M+198bp12mo
A/R Days Reduction5200.0%3800.0%$1.8M+122bp9mo
Clean Claim Rate88.0%96.0%$92K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$3.0M
Cost to Collect
$2.9M
Denial Rate Reduction
$2.8M
A/R Days Reduction
$1.8M
Clean Claim Rate
$92K
Total EBITDA Uplift$10.6M
Current EBITDA$2.0M
+ RCM Uplift+$10.6M
Pro Forma EBITDA$12.6M
Current Margin1.4%
Pro Forma Margin8.7%
WC Released (1x)$5.5M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$3.1M$119.1M38.82x107.9%
Base (11x exit)10.0x11.0x$3.1M$132.0M43.02x112.2%
Bull Case9.0x11.0x$2.8M$168.0M60.82x127.4%
Bull (12x exit)9.0x12.0x$2.8M$184.0M66.65x131.6%
Bear Case11.0x10.0x$3.4M$65.1M19.30x80.8%
Bear (11x exit)11.0x11.0x$3.4M$72.7M21.55x84.8%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
LowLow net-to-gross ratioLarge contractual allowances suggest pricing discipline issues. Mitigant: payer renegotiation is an additional upside lever

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 78 hospitals with 98-394 beds
  • Same-state prioritization (n=79)
  • Comp margins: P25=-8.8% / P50=0.6% / P75=7.1%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.